JP2025521099A5 - - Google Patents

Info

Publication number
JP2025521099A5
JP2025521099A5 JP2024566665A JP2024566665A JP2025521099A5 JP 2025521099 A5 JP2025521099 A5 JP 2025521099A5 JP 2024566665 A JP2024566665 A JP 2024566665A JP 2024566665 A JP2024566665 A JP 2024566665A JP 2025521099 A5 JP2025521099 A5 JP 2025521099A5
Authority
JP
Japan
Prior art keywords
indazole
pyridine
amino
alkyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521099A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2023/051242 external-priority patent/WO2023218201A1/en
Publication of JP2025521099A publication Critical patent/JP2025521099A/ja
Publication of JP2025521099A5 publication Critical patent/JP2025521099A5/ja
Pending legal-status Critical Current

Links

JP2024566665A 2022-05-11 2023-05-11 Ikk阻害剤 Pending JP2025521099A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2206901.7 2022-05-11
GB202206901 2022-05-11
PCT/GB2023/051242 WO2023218201A1 (en) 2022-05-11 2023-05-11 Ikk inhibitors

Publications (2)

Publication Number Publication Date
JP2025521099A JP2025521099A (ja) 2025-07-08
JP2025521099A5 true JP2025521099A5 (enExample) 2026-05-19

Family

ID=86469322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566665A Pending JP2025521099A (ja) 2022-05-11 2023-05-11 Ikk阻害剤

Country Status (8)

Country Link
US (1) US20250304576A1 (enExample)
EP (1) EP4522597A1 (enExample)
JP (1) JP2025521099A (enExample)
KR (1) KR20250011134A (enExample)
CN (1) CN119562945A (enExample)
AU (1) AU2023268009A1 (enExample)
CA (1) CA3250036A1 (enExample)
WO (1) WO2023218201A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202306601D0 (en) * 2023-05-04 2023-06-21 Cancer Research Tech Ltd Inhibitor compounds
CN117843563A (zh) * 2024-01-02 2024-04-09 沈阳药科大学 含脲片段的CDKs抑制剂衍生物及其药物组合物和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
WO2008132121A1 (en) * 2007-04-26 2008-11-06 Glaxo Group Limited Lh-indazole-3-amine compounds as ikk1 inhibitors
CN101790526A (zh) * 2007-06-08 2010-07-28 雅培制药有限公司 用作激酶抑制剂的5-杂芳基取代的吲唑化合物

Similar Documents

Publication Publication Date Title
CN101912400B (zh) 用于治疗癌症的5-氨基-2,4,7-三氧代-3,4,7,8-四氢-2H-吡啶并[2,3-d]嘧啶衍生物和相关化合物
US7279473B2 (en) Pyrazolopyridazine derivatives
JP4064818B2 (ja) 6−置換ピリド−ピリミジン類
KR100225720B1 (ko) 부신피질자극호르몬-방출 인자 길항제로서의 피라졸로피리미딘을 포함하는 약학 조성물
US20070054915A1 (en) p38 MAP kinase inhibitors and methods for using the same
BG106853A (bg) Антагонисти на кортикотропин освобождаващ фактор
PT764166E (pt) Antagonistas de factor de libertacao de corticotropina
AU2020284742B2 (en) Novel compounds for inhibition of Janus Kinase 1
JP2009502734A (ja) Lck阻害剤としての縮合複素環
TW201002327A (en) Cytokine inhibitors
JP2010513283A5 (enExample)
RU2009123841A (ru) Замещенные производные 2,5-дигидро-3н-пиразоло[4,3-c]пиридазин-3-она, их получение и их применение в терапии
JP2007521287A5 (enExample)
CA3211584A1 (en) Heterocyclic derivatives as janus kinase inhibitors
JP2013523749A5 (enExample)
JP2004507523A (ja) 選択的セロトニン再取込み阻害剤としてのフェノキシベンジルアミン誘導体
KR20080002865A (ko) 피리도[2,3-d]피리미딘-7-온 및3,4-디히드로피리미도[4,5-d]피리미딘-2(1h)-온유도체의 제조 방법
CN121285552A (zh) 作为ddr抑制剂的杂芳基衍生物
WO2025245105A1 (en) Kras inhibitors
JP2011509288A5 (enExample)
JP2007523207A (ja) カンナビノイド受容体モジュレーターとしてのピリミジン誘導体
WO2004101567A1 (en) 2-SUBSTITUTED PHENYL -6,8-DIALKYL-3H-IMIDAZOLE [1,5a][1,3,5] TRIAZINE -4- ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
RU2023126218A (ru) Гетероциклические производные в качестве ингибиторов janus-киназы
JP2007506745A5 (enExample)
RU2021135875A (ru) ;новые соединения для ингибирования янус-киназы 1